Sanara Medtech Inc (SMTI) - Total Assets
Based on the latest financial reports, Sanara Medtech Inc (SMTI) holds total assets worth $72.94 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore SMTI operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Sanara Medtech Inc - Total Assets Trend (1999–2025)
This chart illustrates how Sanara Medtech Inc's total assets have evolved over time, based on quarterly financial data. See Sanara Medtech Inc shareholders equity for net asset value and shareholders' equity analysis.
Sanara Medtech Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Sanara Medtech Inc's total assets of $72.94 Million consist of 46.0% current assets and 54.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 22.7% |
| Accounts Receivable | $12.00 Million | 16.5% |
| Inventory | $3.95 Million | 5.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $18.64 Million | 25.6% |
| Goodwill | $3.60 Million | 4.9% |
Asset Composition Trend (1999–2025)
This chart illustrates how Sanara Medtech Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SMTI company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sanara Medtech Inc's current assets represent 46.0% of total assets in 2025, a decrease from 63.6% in 1999.
- Cash Position: Cash and equivalents constituted 22.7% of total assets in 2025, up from 1.8% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 29.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is intangible assets at 25.6% of total assets.
Sanara Medtech Inc Competitors by Total Assets
Key competitors of Sanara Medtech Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥912.66 Million |
|
Interojo Inc
KQ:119610
|
Korea | ₩252.22 Billion |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
Sanara Medtech Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.80 | 2.18 | 10.07 |
| Quick Ratio | 1.59 | 2.00 | 9.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $14.92 Million | $18.02 Million | $28.41 Million |
Sanara Medtech Inc - Advanced Valuation Insights
This section examines the relationship between Sanara Medtech Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 26.40 |
| Latest Market Cap to Assets Ratio | 2.14 |
| Asset Growth Rate (YoY) | -17.2% |
| Total Assets | $72.94 Million |
| Market Capitalization | $155.84 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Sanara Medtech Inc's assets at a significant premium (2.14x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Sanara Medtech Inc's assets decreased by 17.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sanara Medtech Inc (1999–2025)
The table below shows the annual total assets of Sanara Medtech Inc from 1999 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $72.94 Million | -17.20% |
| 2024-12-31 | $88.09 Million | +19.25% |
| 2023-12-31 | $73.87 Million | +21.03% |
| 2022-12-31 | $61.04 Million | +67.70% |
| 2021-12-31 | $36.40 Million | +270.40% |
| 2020-12-31 | $9.83 Million | -11.61% |
| 2019-12-31 | $11.12 Million | +265.45% |
| 2018-12-31 | $3.04 Million | +37.16% |
| 2017-12-31 | $2.22 Million | +2.14% |
| 2016-12-31 | $2.17 Million | +56.01% |
| 2015-12-31 | $1.39 Million | -7.11% |
| 2014-12-31 | $1.50 Million | +53.34% |
| 2013-12-31 | $977.15K | -29.88% |
| 2012-12-31 | $1.39 Million | -63.64% |
| 2011-12-31 | $3.83 Million | -43.50% |
| 2010-12-31 | $6.78 Million | +42.13% |
| 2009-12-31 | $4.77 Million | +3045.79% |
| 2008-12-31 | $151.71K | -62.61% |
| 2007-12-31 | $405.73K | -18.25% |
| 2006-12-31 | $496.29K | +92.50% |
| 2005-12-31 | $257.81K | +26.73% |
| 2004-12-31 | $203.43K | -86.10% |
| 2001-12-31 | $1.46 Million | +28.81% |
| 2000-12-31 | $1.14 Million | -21.64% |
| 1999-12-31 | $1.45 Million | -- |
About Sanara Medtech Inc
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and seco… Read more